Company Filing History:
Years Active: 1994
Title: The Innovative Contributions of Carter Grandjean
Introduction
Carter Grandjean is an accomplished inventor based in Honey Creek, Iowa. He has made significant contributions to the field of medical diagnostics, particularly through his innovative patent related to bilirubin assay methods. His work has implications for improving the accuracy and reliability of bilirubin testing, which is crucial in various medical applications.
Latest Patents
Carter Grandjean holds a patent for a "Method of Bilirubin Assay." This patent describes a novel approach to assaying both direct and indirect bilirubin levels. The method utilizes organic compounds that can undergo diazotization to produce products with an absorption spectrum similar to bilirubin. Notably, one of the compounds used is ANS (8-anilino-1-naphthalene-sulfonic acid). Although these compounds lack the characteristic yellow color of bilirubin, the deficiency is addressed by adding methyl or ethyl orange. This combination results in a liquid control that remains stable at room temperature for 12 months or more, enhancing the reliability of bilirubin assays.
Career Highlights
Carter Grandjean is associated with Streck Laboratories, Inc., where he applies his expertise in developing innovative diagnostic solutions. His work at the company reflects a commitment to advancing medical technology and improving patient care through accurate diagnostic methods.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Carter Grandjean's contributions to the field of bilirubin assay methods exemplify the impact of innovation in medical diagnostics. His patent not only enhances the accuracy of testing but also demonstrates the importance of research and development in healthcare.